Allos Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allos Pharma. Real-time updates on events, politics, business and more.

Allos Pharma Inc. Expands Intellectual Property Rights for Arbaclofen

September 18, 2023

/PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,...

United Kingdom United States United States Patent Trademark Office Allos Pharma Inc International Society For Autism Research Prnewswire Allos Pharma Inc

Source: prnewswire.com

Allos Pharma Inc. Receives FDA Guidance for the Design of a Phase 3 Trial to Support a New Drug Application for Treatment of Fragile X Syndrome

May 23, 2023

/PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,...

United Kingdom Katie Clapp Hilary Rosselot Drug Administration National Fragilex Foundation Prnewswire Allos Pharma Inc

Source: prnewswire.com

Allos Pharma Inc. presents new positive data analyses at the 18th NFXF International Fragile X Conference

July 14, 2022

CAMBRIDGE, Mass., July 14, 2022 /PRNewswire/ -- Allos Pharma Inc (Allos), a late-stage pharmaceutical company developing therapeutics for neurod...

United Kingdom United States Allos Pharma Elizabeth Berry Kravis Allos Pharma Inc Rush University Medical Center

Source: businessinsider.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Allos Pharma News Today

Allos Pharma Inc. Expands Intellectual Property Rights for Arbaclofen

Allos Pharma Inc. Receives FDA Guidance for the Design of a Phase 3 Trial to Support a New Drug Application for Treatment of Fragile X Syndrome

Allos Pharma Inc. presents new positive data analyses at the 18th NFXF International Fragile X Conference

Explore More Categories